Presence of Circulating Anti-Myosin Antibodies in Endomyocardial Fibrosis

BACKGROUND: Endomyocardial Fibrosis (EMF) is a tropical restrictive cardiomyopathy of unknown etiology with high prevalence in Sub-Saharan Africa, for which it is unclear whether the primary target of injury is the endocardial endothelium, the subendocardial fibroblast, the coronary microcirculation...

Descripción completa

Detalles Bibliográficos
Autores principales: Mocumbi, Ana Olga, Latif, Najma, Yacoub, Magdi H.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857887/
https://www.ncbi.nlm.nih.gov/pubmed/20422043
http://dx.doi.org/10.1371/journal.pntd.0000661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857887/
https://www.ncbi.nlm.nih.gov/pubmed/20422043
http://dx.doi.org/10.1371/journal.pntd.0000661

Ejemplares similares